Andrew J. Schwab - Aug 18, 2023 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director, 10%+ Owner
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Aug 18, 2023
Transactions value $
$0
Form type
3
Date filed
8/22/2023, 05:19 PM
Previous filing
Apr 6, 2023
Next filing
Aug 29, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.